Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New xanthine-based adenosine A1 antagonists covered by Endacea patent

Oct. 15, 2004

Two series of glucokinase activators reported by OSI scientists

Oct. 15, 2004

Three novel series of pyridine-based immunosuppressants developed at AstraZeneca

Oct. 14, 2004

Aventis scientists design inhibitors of fungal CIV1 and other kinases

Oct. 14, 2004

New MIF inhibitors prepared and tested at Avanir

Oct. 14, 2004

AstraZeneca team presents new P2X7 antagonists

Oct. 14, 2004

New NO-releasing COX inhibitors in early development at Altana

Oct. 14, 2004

Novel gastric antisecretory agents discovered at Altana

Oct. 14, 2004

Celltech researchers claim anti-IL-1beta antibodies and their use

Oct. 14, 2004

New p38 MAP kinase inhibitors and their use claimed by Pfizer

Oct. 13, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...